Severe meningo-radiculo-nevritis associated with ipilimumab

Autoimmune Inflammatory Myopathy after Treatment with Ipilimumab

(2014) Gary Hunter et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

(2011) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guillain-Barré syndrome after short-course efalizumab treatment

(2010) Marco Turatti et al.   JOURNAL OF NEUROLOGY

Cetuximab-Induced Aseptic Meningitis

(2010) Nail Nagovskiy et al.   Journal of Thoracic Oncology

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

CTLA-4 blockade: therapeutic potential in cancer treatments

(2010) Ahmad Tarhini   OncoTargets and Therapy

Cetuximab-induced aseptic meningitis

(2009) T. M. Feinstein et al.   ANNALS OF ONCOLOGY

Guillain–Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy

(2009) Amine Bouchra et al.   CLINICAL RHEUMATOLOGY

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma

(2009) Erika von Euw et al.   Journal of Translational Medicine

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

(2009) Jedd D Wolchok et al.   LANCET ONCOLOGY

Anti-CTLA4 Monoclonal Antibody Induced Sarcoidosis in a Metastatic Melanoma Patient

(2008) A. Eckert et al.   DERMATOLOGY